Blueprint MedTech: Incubator Hubs (U54 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The Blueprint MedTech program is an NIH incubator that aims to accelerate the development of cutting-edge medical devices to diagnose and treat disorders of the nervous system. This FOA solicits centers ("incubator hubs") to coordinate and manage resources for the Blueprint MedTech program. Hubs will be responsible for providing innovators with resources to support development of human-grade prototypes. Funded hubs are intended to work as a consortium, providing: (1) infrastructure for identifying the most promising technologies, (2) funding for innovators to support product definition and development, (3) funding for resources to assist innovators to support definition and development (e.g., prototype manufacturing, bench testing), and (4) access to relevant expertise to advise supported innovators.

Companion FOAs:

PAR-21-282 , U44 Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional)
PAR-21-315 , UG3UH3 Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)


  • Letter of Intent Due Date(s): September 20, 2021

  • Application Due Date: Oct 20, 2021

PAR-21-314 Expiration Date October 21, 2021

Agency Website

Amount Description

Application budgets are not limited, but need to reflect the anticipated needs of the proposed project. Initial awards will only support the base operating expenses of the Center (i.e., essential operating expenses in the Administrative, Outreach, and Evaluation Cores but not funding for subawards for the innovator subjects and resource providers). Additional funds will be provided if funding is available for compelling innovator subprojects and their linked resource providers.

Funding Type





Engineering and Physical Sciences
Medical - Clinical Science
Medical - Translational

External Deadline

October 20, 2021